0.008834
0.000000
0.000000
-0.000000
0.008834
0.000000
0.000000
-0.000000
0.008834
0.000000
0.000000
0.000000
Weng, J.H.
Wei, T.Y.W.
Hsieh, Y.C.
Huang, C.C.F.
Wu, P.Y.G.
Chen, E.S.W.
Huang, K.F.
Chen, C.J.
Tsai, M.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
24
90.000
90.000
90.000
113.205
113.205
113.205
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C4 H10 N O6 P
199.099
n
PHOSPHOTHREONINE
PHOSPHONOTHREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
54
6219
6229
10.1021/acs.biochem.5b00500
26389808
Uncovering the Mechanism of Forkhead-Associated Domain-Mediated TIFA Oligomerization That Plays a Central Role in Immune Responses.
2015
110
1
CCD
2014-10-26
ADSC QUANTUM 315
SINGLE WAVELENGTH
M
x-ray
1
1.0
1.0
BL13B1
NSRRC
1.0
SYNCHROTRON
NSRRC BEAMLINE BL13B1
16848.533
TRAF-interacting protein with FHA domain-containing protein A
UNP RESIDUES 10-150
1
man
polymer
1455.349
TRAF-interacting protein with FHA domain-containing protein A
UNP RESIDUES 1-12
1
syn
polymer
Putative MAPK-activating protein PM14,Putative NF-kappa-B-activating protein 20,TRAF2-binding protein
Thr9 phosphorylated N-terminal peptide
no
yes
EETVTCLQ(MSE)TVYHPGQLQCGIFQSISFNREKLPSSEVVKFGRNSNICHYTFQDKQVSRVQFSLQLFKKFNSSVLSF
EIKN(MSE)SKKTNLIVDSRELGYLNK(MSE)DLPYRC(MSE)VRFGEYQFL(MSE)EKEDGESLEFFETQFILSPRSLL
Q
EETVTCLQMTVYHPGQLQCGIFQSISFNREKLPSSEVVKFGRNSNICHYTFQDKQVSRVQFSLQLFKKFNSSVLSFEIKN
MSKKTNLIVDSRELGYLNKMDLPYRCMVRFGEYQFLMEKEDGESLEFFETQFILSPRSLLQ
A
polypeptide(L)
no
yes
MTSFEDAD(TPO)EET
MTSFEDADTEET
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Human
sample
1
141
TIFA, T2BP
9606
Homo sapiens
562
Escherichia coli
Biological sequence
pET43.1
1
3.30
62.76
VAPOR DIFFUSION, SITTING DROP
2.1 M DL-malic acid pH7.0
6.5-7.5
277
repository
Initial release
Database references
1
0
2015-10-21
1
1
2015-10-28
Taiwan
Academia Sinica
Taiwan
National Health Research Institutes
N
RCSB
Y
PDBJ
2015-03-06
REL
REL
9606
Human
Homo sapiens
sample
1
12
GLU
10
n
1
GLU
10
A
GLU
11
n
2
GLU
11
A
THR
12
n
3
THR
12
A
VAL
13
n
4
VAL
13
A
THR
14
n
5
THR
14
A
CYS
15
n
6
CYS
15
A
LEU
16
n
7
LEU
16
A
GLN
17
n
8
GLN
17
A
MSE
18
n
9
MSE
18
A
THR
19
n
10
THR
19
A
VAL
20
n
11
VAL
20
A
TYR
21
n
12
TYR
21
A
HIS
22
n
13
HIS
22
A
PRO
23
n
14
PRO
23
A
GLY
24
n
15
GLY
24
A
GLN
25
n
16
GLN
25
A
LEU
26
n
17
LEU
26
A
GLN
27
n
18
GLN
27
A
CYS
28
n
19
CYS
28
A
GLY
29
n
20
GLY
29
A
ILE
30
n
21
ILE
30
A
PHE
31
n
22
PHE
31
A
GLN
32
n
23
GLN
32
A
SER
33
n
24
SER
33
A
ILE
34
n
25
ILE
34
A
SER
35
n
26
SER
35
A
PHE
36
n
27
PHE
36
A
ASN
37
n
28
ASN
37
A
ARG
38
n
29
ARG
38
A
GLU
39
n
30
GLU
39
A
LYS
40
n
31
LYS
40
A
LEU
41
n
32
LEU
41
A
PRO
42
n
33
PRO
42
A
SER
43
n
34
SER
43
A
SER
44
n
35
SER
44
A
GLU
45
n
36
GLU
45
A
VAL
46
n
37
VAL
46
A
VAL
47
n
38
VAL
47
A
LYS
48
n
39
LYS
48
A
PHE
49
n
40
PHE
49
A
GLY
50
n
41
GLY
50
A
ARG
51
n
42
ARG
51
A
ASN
52
n
43
ASN
52
A
SER
53
n
44
SER
53
A
ASN
54
n
45
ASN
54
A
ILE
55
n
46
ILE
55
A
CYS
56
n
47
CYS
56
A
HIS
57
n
48
HIS
57
A
TYR
58
n
49
TYR
58
A
THR
59
n
50
THR
59
A
PHE
60
n
51
PHE
60
A
GLN
61
n
52
GLN
61
A
ASP
62
n
53
ASP
62
A
LYS
63
n
54
LYS
63
A
GLN
64
n
55
GLN
64
A
VAL
65
n
56
VAL
65
A
SER
66
n
57
SER
66
A
ARG
67
n
58
ARG
67
A
VAL
68
n
59
VAL
68
A
GLN
69
n
60
GLN
69
A
PHE
70
n
61
PHE
70
A
SER
71
n
62
SER
71
A
LEU
72
n
63
LEU
72
A
GLN
73
n
64
GLN
73
A
LEU
74
n
65
LEU
74
A
PHE
75
n
66
PHE
75
A
LYS
76
n
67
LYS
76
A
LYS
77
n
68
LYS
77
A
PHE
78
n
69
PHE
78
A
ASN
79
n
70
ASN
79
A
SER
80
n
71
SER
80
A
SER
81
n
72
SER
81
A
VAL
82
n
73
VAL
82
A
LEU
83
n
74
LEU
83
A
SER
84
n
75
SER
84
A
PHE
85
n
76
PHE
85
A
GLU
86
n
77
GLU
86
A
ILE
87
n
78
ILE
87
A
LYS
88
n
79
LYS
88
A
ASN
89
n
80
ASN
89
A
MSE
90
n
81
MSE
90
A
SER
91
n
82
SER
91
A
LYS
92
n
83
LYS
92
A
LYS
93
n
84
LYS
93
A
THR
94
n
85
THR
94
A
ASN
95
n
86
ASN
95
A
LEU
96
n
87
LEU
96
A
ILE
97
n
88
ILE
97
A
VAL
98
n
89
VAL
98
A
ASP
99
n
90
ASP
99
A
SER
100
n
91
SER
100
A
ARG
101
n
92
ARG
101
A
GLU
102
n
93
GLU
102
A
LEU
103
n
94
LEU
103
A
GLY
104
n
95
GLY
104
A
TYR
105
n
96
TYR
105
A
LEU
106
n
97
LEU
106
A
ASN
107
n
98
ASN
107
A
LYS
108
n
99
LYS
108
A
MSE
109
n
100
MSE
109
A
ASP
110
n
101
ASP
110
A
LEU
111
n
102
LEU
111
A
PRO
112
n
103
PRO
112
A
TYR
113
n
104
TYR
113
A
ARG
114
n
105
ARG
114
A
CYS
115
n
106
CYS
115
A
MSE
116
n
107
MSE
116
A
VAL
117
n
108
VAL
117
A
ARG
118
n
109
ARG
118
A
PHE
119
n
110
PHE
119
A
GLY
120
n
111
GLY
120
A
GLU
121
n
112
GLU
121
A
TYR
122
n
113
TYR
122
A
GLN
123
n
114
GLN
123
A
PHE
124
n
115
PHE
124
A
LEU
125
n
116
LEU
125
A
MSE
126
n
117
MSE
126
A
GLU
127
n
118
GLU
127
A
LYS
128
n
119
LYS
128
A
GLU
129
n
120
GLU
129
A
ASP
130
n
121
ASP
130
A
GLY
131
n
122
GLY
131
A
GLU
132
n
123
GLU
132
A
SER
133
n
124
SER
133
A
LEU
134
n
125
LEU
134
A
GLU
135
n
126
GLU
135
A
PHE
136
n
127
PHE
136
A
PHE
137
n
128
PHE
137
A
GLU
138
n
129
GLU
138
A
THR
139
n
130
THR
139
A
GLN
140
n
131
GLN
140
A
PHE
141
n
132
PHE
141
A
ILE
142
n
133
ILE
142
A
LEU
143
n
134
LEU
143
A
SER
144
n
135
SER
144
A
PRO
145
n
136
PRO
145
A
ARG
146
n
137
ARG
146
A
SER
147
n
138
SER
147
A
LEU
148
n
139
LEU
148
A
LEU
149
n
140
LEU
149
A
GLN
150
n
141
GLN
150
A
MET
1
n
1
MET
1
B
THR
2
n
2
THR
2
B
SER
3
n
3
SER
3
B
PHE
4
n
4
PHE
4
B
GLU
5
n
5
GLU
5
B
ASP
6
n
6
ASP
6
B
ALA
7
n
7
ALA
7
B
ASP
8
n
8
ASP
8
B
TPO
9
n
9
TPO
9
B
GLU
10
n
10
GLU
10
B
GLU
11
n
11
GLU
11
B
THR
12
n
12
THR
12
B
author_and_software_defined_assembly
PISA
2
dimeric
950
-3
8490
A
MSE
18
modified residue
A
MSE
9
MET
A
MSE
90
modified residue
A
MSE
81
MET
A
MSE
109
modified residue
A
MSE
100
MET
A
MSE
116
modified residue
A
MSE
107
MET
A
MSE
126
modified residue
A
MSE
117
MET
B
TPO
9
modified residue
B
TPO
9
THR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LEU
41
A
N
LEU
32
A
O
PHE
137
A
O
PHE
128
A
O
ILE
142
A
O
ILE
133
A
N
VAL
20
A
N
VAL
11
A
N
THR
19
A
N
THR
10
A
O
LEU
125
A
O
LEU
116
A
O
PHE
124
A
O
PHE
115
A
N
VAL
117
A
N
VAL
108
A
O
ARG
118
A
O
ARG
109
A
N
ILE
97
A
N
ILE
88
A
N
LEU
96
A
N
LEU
87
A
O
LEU
103
A
O
LEU
94
A
O
TYR
58
A
O
TYR
49
A
N
GLY
50
A
N
GLY
41
A
N
PHE
49
A
N
PHE
40
A
O
GLN
69
A
O
GLN
60
A
N
PHE
75
A
N
PHE
66
A
O
SER
84
A
O
SER
75
A
N
ILE
87
A
N
ILE
78
A
O
MSE
109
A
O
MSE
100
1
A
CG
LYS
63
A
CG
LYS
54
1
Y
1
A
CD
LYS
63
A
CD
LYS
54
1
Y
1
A
CE
LYS
63
A
CE
LYS
54
1
Y
1
A
NZ
LYS
63
A
NZ
LYS
54
1
Y
1
A
CG
LYS
93
A
CG
LYS
84
1
Y
1
A
CD
LYS
93
A
CD
LYS
84
1
Y
1
A
CE
LYS
93
A
CE
LYS
84
1
Y
1
A
NZ
LYS
93
A
NZ
LYS
84
1
Y
1
A
CG
GLU
129
A
CG
GLU
120
1
Y
1
A
CD
GLU
129
A
CD
GLU
120
1
Y
1
A
OE1
GLU
129
A
OE1
GLU
120
1
Y
1
A
OE2
GLU
129
A
OE2
GLU
120
1
Y
1
A
CG
GLU
132
A
CG
GLU
123
1
Y
1
A
CD
GLU
132
A
CD
GLU
123
1
Y
1
A
OE1
GLU
132
A
OE1
GLU
123
1
Y
1
A
OE2
GLU
132
A
OE2
GLU
123
1
Y
1
A
CG
GLN
150
A
CG
GLN
141
1
Y
1
A
CD
GLN
150
A
CD
GLN
141
1
Y
1
A
OE1
GLN
150
A
OE1
GLN
141
1
Y
1
A
NE2
GLN
150
A
NE2
GLN
141
1
Y
1
B
OG1
THR
12
B
OG1
THR
12
1
Y
1
B
CG2
THR
12
B
CG2
THR
12
1
Y
1
A
A
SG
NH2
CYS
ARG
15
38
1.19
1
A
B
OG
OE1
SER
GLU
53
5
1.21
1
A
B
NH1
O1P
ARG
TPO
67
9
1.95
1
A
GLN
27
-95.76
-75.29
1
A
MSE
90
-147.82
26.12
1
A
LYS
93
-58.66
-72.86
1
A
SER
100
80.78
0.90
186.460
44.6320
16.050
0.0000
0.0000
0.0000
0.0000
0.0000
0.0000
0.9260
0.8880
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
0.2386
0.2134
0.2145
3.1200
20.0000
226
4543
4.7000
99.3700
0.0040
0.0000
RANDOM
1
THROUGHOUT
0.000
0.3540
0.3960
0.8000
0.8000
1.2000
MAXIMUM LIKELIHOOD
MASK
3.1200
20.0000
0
1240
0
0
1240
153
0.3210
0.3160
3.2020
17
324
341
20
100.0000
3.100
20.000
4YM4
4922
0.161
0.035
0.164
0.947
1
23.556
6.300
107113
21.800
100.000
0.885
3.100
3.210
471
0.904
0.206
0.909
0.955
1
19.200
0
100.000
0.671
3.210
3.340
478
0.939
0.145
0.687
0.954
1
22.100
0
100.000
0.450
3.340
3.490
474
0.995
0.095
0.461
0.923
1
23.100
0
100.000
0.325
3.490
3.670
478
0.984
0.069
0.332
0.948
1
23.100
0
100.000
0.214
3.670
3.900
480
0.994
0.045
0.219
0.985
1
23.100
0
100.000
0.152
3.900
4.200
479
0.995
0.032
0.155
0.955
1
22.800
0
100.000
0.097
4.200
4.620
488
0.997
0.021
0.099
0.952
1
22.500
0
100.000
0.079
4.620
5.270
500
0.998
0.017
0.081
0.917
1
22.200
0
100.000
0.099
5.270
6.610
513
0.998
0.022
0.102
1.111
1
21.300
0
100.000
0.040
6.610
20.000
561
0.999
0.009
0.041
0.769
1
18.800
0
100.000
data scaling
HKL-2000
refinement
REFMAC
5.7.0032
data extraction
PDB_EXTRACT
3.15
data reduction
HKL-2000
phasing
PHENIX
Truncated Human TIFA, MET-THR-SER-PHE-GLU-ASP-ALA-ASP-TPO-GLU-GLU-THR
Truncated Human TIFA in complex with its Thr9 phosphorylated N-terminal peptide 1-15
1
N
N
2
N
N
A
GLY
29
A
GLY
20
HELX_P
A
ILE
34
A
ILE
25
5
AA1
6
covale
1.308
both
A
GLN
17
A
C
GLN
8
1_555
A
MSE
18
A
N
MSE
9
1_555
covale
1.312
both
A
MSE
18
A
C
MSE
9
1_555
A
THR
19
A
N
THR
10
1_555
covale
1.311
both
A
ASN
89
A
C
ASN
80
1_555
A
MSE
90
A
N
MSE
81
1_555
covale
1.310
both
A
MSE
90
A
C
MSE
81
1_555
A
SER
91
A
N
SER
82
1_555
covale
1.323
both
A
LYS
108
A
C
LYS
99
1_555
A
MSE
109
A
N
MSE
100
1_555
covale
1.315
both
A
MSE
109
A
C
MSE
100
1_555
A
ASP
110
A
N
ASP
101
1_555
covale
1.322
both
A
CYS
115
A
C
CYS
106
1_555
A
MSE
116
A
N
MSE
107
1_555
covale
1.311
both
A
MSE
116
A
C
MSE
107
1_555
A
VAL
117
A
N
VAL
108
1_555
covale
1.328
both
A
LEU
125
A
C
LEU
116
1_555
A
MSE
126
A
N
MSE
117
1_555
covale
1.311
both
A
MSE
126
A
C
MSE
117
1_555
A
GLU
127
A
N
GLU
118
1_555
covale
1.318
both
B
ASP
8
B
C
ASP
8
1_555
B
TPO
9
B
N
TPO
9
1_555
covale
1.310
both
B
TPO
9
B
C
TPO
9
1_555
B
GLU
10
B
N
GLU
10
1_555
SIGNALING PROTEIN
Complex, FHA domian, adaptor, SIGNALING PROTEIN
TIFA_HUMAN
UNP
1
10
Q96CG3
EETVTCLQMTVYHPGQLQCGIFQSISFNREKLPSSEVVKFGRNSNICHYTFQDKQVSRVQFSLQLFKKFNSSVLSFEIKN
MSKKTNLIVDSRELGYLNKMDLPYRCMVRFGEYQFLMEKEDGESLEFFETQFILSPRSLLQ
TIFA_HUMAN
UNP
2
1
Q96CG3
MTSFEDADTEET
10
150
4YM4
10
150
Q96CG3
A
1
1
141
1
12
4YM4
1
12
Q96CG3
B
2
1
12
7
5
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
39
A
GLU
30
A
PRO
42
A
PRO
33
A
PHE
136
A
PHE
127
A
LEU
143
A
LEU
134
A
THR
14
A
THR
5
A
TYR
21
A
TYR
12
A
TYR
122
A
TYR
113
A
GLU
129
A
GLU
120
A
ARG
114
A
ARG
105
A
PHE
119
A
PHE
110
A
LEU
96
A
LEU
87
A
VAL
98
A
VAL
89
A
ARG
101
A
ARG
92
A
LEU
103
A
LEU
94
A
TYR
58
A
TYR
49
A
THR
59
A
THR
50
A
VAL
47
A
VAL
38
A
GLY
50
A
GLY
41
A
VAL
68
A
VAL
59
A
LYS
76
A
LYS
67
A
LEU
83
A
LEU
74
A
ASN
89
A
ASN
80
A
LYS
108
A
LYS
99
A
ASP
110
A
ASP
101
208
P 42 3 2